{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By THE NEW YORK TIMES", "person": [], "organization": "THE NEW YORK TIMES"}, "abstract": null, "type_of_material": "News", "word_count": "543", "lead_paragraph": "This week, the Food and Drug Administration is expected to approve Repatha; several key pieces of housing data will be released; and Mylan shareholders may advance a takeover bid.", "pub_date": "2015-08-24T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Data on Home Prices and the F.D.A.\u2019s Decision on a Cholesterol-Lowering Drug", "content_kicker": "The Week Ahead", "kicker": "The Week Ahead"}, "snippet": "This week, the Food and Drug Administration is expected to approve Repatha; several key pieces of housing data will be released; and Mylan shareholders may advance a takeover bid.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/08/24/business/data-on-home-prices-and-the-fdas-decision-on-a-cholesterol-lowering-drug.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Economic Conditions and Trends", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Japan", "name": "glocations"}, {"rank": "3", "is_major": "N", "value": "Consumer Price Index", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Real Estate and Housing (Residential)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Cholesterol", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Federal Reserve System", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}], "blog": [], "_id": "55da7a6d38f0d82b75b77486", "source": "The New York Times"}